A Comparison of the Convolution and TMR10 Treatment Planning Algorithms for Gamma Knife Radiosurgery
Overview
Affiliations
Aims: To compare the accuracies of the convolution and TMR10 Gamma Knife treatment planning algorithms, and assess the impact upon clinical practice of implementing convolution-based treatment planning.
Methods: Doses calculated by both algorithms were compared against ionisation chamber measurements in homogeneous and heterogeneous phantoms. Relative dose distributions calculated by both algorithms were compared against film-derived 2D isodose plots in a heterogeneous phantom, with distance-to-agreement (DTA) measured at the 80%, 50% and 20% isodose levels. A retrospective planning study compared 19 clinically acceptable metastasis convolution plans against TMR10 plans with matched shot times, allowing novel comparison of true dosimetric parameters rather than total beam-on-time. Gamma analysis and dose-difference analysis were performed on each pair of dose distributions.
Results: Both algorithms matched point dose measurement within ±1.1% in homogeneous conditions. Convolution provided superior point-dose accuracy in the heterogeneous phantom (-1.1% v 4.0%), with no discernible differences in relative dose distribution accuracy. In our study convolution-calculated plans yielded D 6.4% (95% CI:5.5%-7.3%,p<0.001) less than shot matched TMR10 plans. For gamma passing criteria 1%/1mm, 16% of targets had passing rates >95%. The range of dose differences in the targets was 0.2-4.6Gy.
Conclusions: Convolution provides superior accuracy versus TMR10 in heterogeneous conditions. Implementing convolution would result in increased target doses therefore its implementation may require a revaluation of prescription doses.
Fager M, Gubanski M, Carlsson Tedgren A, Benmakhlouf H Acta Oncol. 2025; 64:319-325.
PMID: 40008908 PMC: 11884334. DOI: 10.2340/1651-226X.2025.41924.
Zap-X Radiosurgery System: Initial Clinical Experience in a Recurrent Gamma Knife Case Series.
Horiba A, Hayashi M, Maruyama T, Nomura R, Kim P, Kawamata T Cureus. 2024; 16(11):e74005.
PMID: 39712764 PMC: 11660191. DOI: 10.7759/cureus.74005.
Watanabe Y, Mathew D, Natanasabapathi G J Radiosurg SBRT. 2023; 8(4):297-303.
PMID: 37416335 PMC: 10322173.
Park S, Choi D, Jung I, Chang K, Kim M, Jung H Biomed Eng Lett. 2022; 12(4):359-367.
PMID: 36238366 PMC: 9550914. DOI: 10.1007/s13534-022-00227-x.
Yuan J, Fredman E, Jin J, Choi S, Mansur D, Sloan A Technol Cancer Res Treat. 2021; 20:15330338211046433.
PMID: 34632872 PMC: 8504229. DOI: 10.1177/15330338211046433.